Optimizing the Total Cost of Ownership by C2 PHARMA’s CEO, Andrew Badrot Posted on 30. October 202330. October 2023 by admin_c2p
Senior Manager Business Development, Serge Tarabay PharmaSource Podcast Interview Posted on 18. October 202318. October 2023 by admin_c2p
C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona Posted on 17. October 202317. October 2023 by admin_c2p
Head of Quality, Tara Fitzpatrick Interviews with Pharma Techs Felicity Thomas Posted on 2. October 2023 by admin_c2p